SCHEMBL7916517

SCHEMBL7916517

COc1ccc(-n2nnnc2C(F)(F)F)nc1Br

nearest known ligand 0.37

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 12/20 0.36
KDM4E B2RXH2 5/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAPT P10636 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CRHR1 P34998 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6923107 0.83 TACR1 (0.36) TACR1KDM4EALDH1A1HPGDCYP1A2
SCHEMBL8176205 0.76 TACR1 (0.48) TACR1KDM4EALDH1A1HPGDMAPT
SCHEMBL7919134 0.73 ALDH1A1 (0.33) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL7916641 0.72 CHRNB2 (0.45) TACR1
SCHEMBL6920657 0.71 ALDH1A1 (0.41) TACR1KDM4EALDH1A1HPGDCYP1A2
SCHEMBL4205517 0.71 KCNN4 (0.56) TACR1ALDH1A1HPGDMAPTNPSR1
SCHEMBL13629596 0.71 TACR1 (0.46) TACR1KDM4EALDH1A1HPGDMAPT
SCHEMBL8530555 0.70 TACR1 (0.46) TACR1KDM4EALDH1A1HPGDMAPT
SCHEMBL13801192 0.70 P2RX7 (0.40) ALDH1A1HPGDMAPT
SCHEMBL6906887 0.69 TACR1 (0.35) TACR1KDM4EALDH1A1HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6225320-B1 TREATMENT OF PAIN, INFLAMMATION, MIGRAINE, EMESIS AND POSTTHERPETIC NEURALGIA MERCK SHARP & DOHME LTD. (GB) 2001-05-01 US disclosed
EP-0989987-A1 SPIRO-AZACYCLIC DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LTD. (GB) 2000-04-05 EP disclosed
US-5929094-A NOVEL 3-((SUBSTITUTED) HETEROCYCLE),6-(SUBSTITUTED PHENYL)-1-OXASPIRO(4.4)NONANE DERIVATIVES; ANTAGONIZING THE EFFECT OF SUBSTANCE P BY ADMINISTERING TO BLOCK NEUROKININ-1 RECEPTORS; TREATING INFLAMMATION, MIGRAINE, EMESIS AND ASTHMA MERCK & CO., INC. (US) 1999-07-27 US disclosed
WO-1998054187-A1 SPIRO-AZACYCLIC DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LIMITED (GB) 1998-12-03 WO disclosed